ArticleProtoplasma2025
Identification of adipose-proximal biomarkers in breast cancer using weighted gene co-expression network analysis.
Article in Protoplasma, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast cancer is a widely studied cancer that involves multiple complex molecular mechanisms in its development and progression. To gain a deeper understanding of the molecular mechanisms of breast cancer and to search for potential therapeutic targets and prognostic markers, we performed an in-depth analysis of breast cancer gene expression data using weighted co-expression network analysis. First, we downloaded breast cancer-related gene expression data from public databases and performed weighted co-expression network analysis. Through the analysis, we identified the purple modules that are closely related to breast cancer and screened out 224 genes for further functional enrichment analysis. To construct the protein interactions network, we selected 90 of these genes for analysis after screening. The GO enrichment analysis mainly focused on the response of extracellular matrix organization to hormones, negative regulation of angiogenesis, positive regulation of cell proliferation, positive regulation of epithelial-to-mesenchymal transition, transforming growth factor β-receptor signaling pathway, localization of proteins to membranes, response to cortisol, positive regulation of protein kinase B signaling, and other biological processes. KEGG pathway enrichment analysis mainly includes PI3K-Akt signaling pathway, TGF-β signaling pathway, cell cycle, proteoglycan in cancer, MAPK signaling pathway, and many other cancer disease pathways. Finally, we screened the key genes in the protein interactions network using Cytoscape's MCODE plug-in and identified nine key markers, namely THBS2, ACTA2, TIMP1, VCAN, TGFB2, FN1, BGN, CCN2, and TAGLN. These genes may play an important role in the pathogenesis of breast cancer providing new ideas for breast cancer treatment and prognosis.
Indexed as
Identifiers
40498134What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.